Ali Faraz 4

4 · Tenaya Therapeutics, Inc. · Filed Feb 5, 2026

AI-generated summary of this filing

Updated Feb 5, 2026

Tenaya (TNYA) CEO Ali Faraz Receives Equity Awards

What Happened

Ali Faraz, CEO of Tenaya Therapeutics (TNYA), received equity awards on February 3, 2026: 158,600 restricted stock units (RSUs) granted (acquired at $0) and a derivative award covering 952,250 shares (an option/derivative, also $0). Total instruments awarded on the date equal 1,110,850 shares. These were grants under the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan and do not represent an open‑market purchase or sale.

Key Details

Transaction date: 2026-02-03; Form filed: 2026-02-05 (filed two days after the transaction).
Prices: both awards reported at $0.00 (typical for grants/awards—no cash paid at grant).
Vesting: RSUs vest as to 1/8th on August 15, 2026, then 1/8th every six months thereafter (F1, F2). The option vests monthly at 1/48th beginning one month after the grant date (F4).
Additional note (F3): the filing references 369,875 shares that will be issued upon vesting of restricted stock units.
Shares owned after the transaction: not specified in the provided filing excerpt.
Timeliness: filing appears timely (filed two days after the transaction).

Context

These are grants/awards (A) — not purchases or sales — so they do not signal immediate buying or selling of stock. Value is realized only if/when awards vest and, for options, if exercised. Vesting schedules stagger future potential dilution and align incentives over time.

Form 4

Period: 2026-02-03

DirectorChief Executive Officer

Transactions

Award
Common Stock
[F1][F2][F3]
2026-02-03+158,600→ 458,266 total
Award
Stock Option (Right to buy)
[F4]
2026-02-03+952,250→ 952,250 total
Exercise: $0.92From: 2026-03-03Exp: 2036-02-02→ Common Stock (952,250 underlying)

Footnotes (4)

[F1]Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock.
[F2]The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2026, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested.
[F3]Includes 369,875 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
[F4]Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested.

Signature

/s/ Jennifer Drimmer Rokovich, Attorney in Fact|2026-02-05

1 file